Enanta Pharmaceuticals, Inc. (ENTA): Price and Financial Metrics

ENTA POWR Grades

• Value is the dimension where ENTA ranks best; there it ranks ahead of 76.44% of US stocks.
• ENTA's strongest trending metric is Stability; it's been moving down over the last 163 days.
• ENTA ranks lowest in Momentum; there it ranks in the 9th percentile.

ENTA Stock Summary

• Of note is the ratio of Enanta Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 6.46% of US stocks have a lower such ratio.
• The ratio of debt to operating expenses for Enanta Pharmaceuticals Inc is higher than it is for about just 7.64% of US stocks.
• ENTA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 7.71% of US stocks.
• If you're looking for stocks that are quantitatively similar to Enanta Pharmaceuticals Inc, a group of peers worth examining would be PTGX, XENE, SGMO, NRIX, and RVMD.
• Visit ENTA's SEC page to see the company's official filings. To visit the company's web site, go to www.enanta.com.

ENTA Valuation Summary

• In comparison to the median Healthcare stock, ENTA's price/sales ratio is 213.16% higher, now standing at 11.9.
• Over the past 103 months, ENTA's price/sales ratio has gone up 7.7.
• Over the past 103 months, ENTA's EV/EBIT ratio has gone down 18.3.

Below are key valuation metrics over time for ENTA.

ENTA Growth Metrics

Its year over year revenue growth rate is now at -46.46%.
• Its year over year cash and equivalents growth rate is now at 3.72%.
• The 2 year cash and equivalents growth rate now stands at 10.98%.

ENTA's revenue has moved down $5,740,000 over the prior 49 months.

The table below shows ENTA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	97.074	-69.996	-78.996
2021-06-30	97.13	-64.436	-83.738
2021-03-31	94.159	-39.418	-73.979
2020-12-31	101.646	-20.165	-57.939
2020-09-30	122.473	7.088	-36.168
2020-06-30	150.155	31.094	2.364

ENTA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ENTA has a Quality Grade of C, ranking ahead of 57.4% of graded US stocks.
• ENTA's asset turnover comes in at 0.206 -- ranking 196th of 682 Pharmaceutical Products stocks.
• GILD, ALT, and RDUS are the stocks whose asset turnover ratios are most correlated with ENTA.

The table below shows ENTA's key quality metrics over time.